Guggenheim Capital LLC Nevro Corp Transaction History

Guggenheim Capital LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$40.85 - $77.67 $126,471 - $240,466	-3,096 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$59.95 - $92.06 $26,078 - $40,046	-435 Reduced 12.32%	3,096 $224,000
Q4 2021 Feb 14, 2022	BUY	$81.07 - $121.29 $286,258 - $428,274	3,531 New	3,531 $286,000
Q1 2021 May 13, 2021	SELL	$132.81 - $182.18 $162,028 - $222,259	-1,220 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$138.17 - $184.34 $168,567 - $224,894	1,220 New	1,220 $211,000
Q4 2017 Feb 14, 2018	SELL	$65.94 - $93.31 $319,017 - $451,433	-4,838 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$80.87 - $91.08 $391,249 - $440,645	4,838	4,838 $439,000

168

37.8M

44K

1.69M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $187M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.